The US has announced an exciting plan to cut biosimilar development costs by 50% for India’s Biocon, a top executive told Reuters. This ambitious move aims to boost access to affordable biologics and strengthen the growing pharmaceutical alliance between the US and India
Novo Nordisk (NVO:NYSE) has boldly cut the price of its weight-loss drug Wegovy in India, making it more affordable and set to take the lead in the fast-growing obesity treatment market
Australia’s Neuren Pharma shares plunged to their lowest level in more than two months after the company dramatically cut its royalty forecast, sparking investor concerns over potential profit declines. Market watchers remain on edge as the stock faces renewed selling pressure
RAMM Pharma Corp. has just shared a crucial update regarding the Canada Post strike, warning shareholders that there may be delays in receiving the company’s meeting materials. Stay alert and watch your inbox for the latest news!
MercadoLibre (MELI) shares dipped after the e-commerce giant made a daring move into Brazil’s pharmacy market. With competition intensifying, investors are closely watching to see what this bold step means for the company’s future. Could this be your next big chance to buy in?
Eli Lilly is gearing up to invest over $1 billion in India, dramatically boosting its manufacturing power to keep pace with the skyrocketing demand across the region, Reuters reports
Advocacy groups are urging regulators to launch a bold anticompetition probe into Big Pharma’s moves after Brexit, accusing the industry of manipulating the market and driving prices sky-high. This call highlights growing concerns over pharmaceutical practices in the evolving post-Brexit landscape
Merck is scaling back its major operations in the UK, raising alarms about Britain’s capacity to retain its thriving life sciences sector amid rising costs and tangled regulations. Industry experts warn that this decision could put the future of the nation’s biotech industry at serious risk
The EU has launched a thorough investigation into France’s Sanofi, zeroing in on its vaccine business amid growing worries about anti-competitive practices. This bold step underscores the heightened scrutiny pharmaceutical giants are under in the post-pandemic world
UK Trade Secretary has launched a fierce critique of the pharmaceutical industry amid heated price negotiations, highlighting soaring drug costs and demanding fairer pricing as critical trade talks loom
Former President Donald Trump has introduced bold new drug tariffs aimed at dramatically cutting U.S. pharmaceutical prices. Experts weigh in on what these changes could mean for the cost of your medications at the pharmacy. Stay updated with USA Today
The US is preparing to impose new tariffs on pharmaceutical imports, kitchen cabinets, furniture, and heavy trucks, intensifying trade tensions. Stay tuned for live updates on how this bold move will impact industries and ignite reactions across the board
Indian pharma stocks plunged sharply following President Trump’s announcement of new drug tariffs. However, analysts urge investors not to panic, highlighting that this sell-off is largely sentiment-driven and the sector’s strong fundamentals remain intact despite the market turbulence
Japan proudly retains its most-favoured nation status for US pharmaceutical tariffs, unlocking valuable trade benefits, Akazawa confirms. This crucial designation not only ensures continued market access but also strengthens the robust bilateral trade partnership, TradingView reports
Brazil’s new clinical research law is transforming the industry by accelerating approvals, enhancing patient protections, and boosting transparency-positioning the country as a vibrant and competitive hotspot for global medical trials
Eli Lilly has temporarily paused UK orders of its diabetes medication Mounjaro ahead of an upcoming price hike, aiming to prevent potential stockpiling. This move carefully manages supply to meet rising demand while preparing for the new pricing structure
The US-Japan trade deal secures the lowest tariff rates ever on semiconductor chips and pharmaceuticals, a Japanese official revealed, setting the stage to turbocharge supply chains and strengthen economic ties, Reuters reports
Celltrion USA is excited to announce the U.S. debut of its denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo), offering innovative and powerful new solutions for osteoporosis and bone health management
Charted: U.S. pharmaceutical drug imports from China highlight a growing dependence on vital raw materials and finished products. Visual Capitalist’s latest data uncovers the powerful trends reshaping the supply chain and transforming the market landscape
Indian-origin pharma magnate Tonmoy Sharma was arrested in Los Angeles for masterminding a massive $149 million healthcare fraud. Authorities say his intricate scheme has sent shockwaves through the US healthcare system, reports the Times of India
